Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: It is confirmed...

IMO a very good summary jonahlomu.

Essentially the 749 patent was a single patent when it was submitted to the USPTO before it was split up. In Europe it was not split up 7 ways.

Share
New Message
Please login to post a reply